Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy in lactic acid bacteria on maintaining physical conditio
- Conditions
- one
- Registration Number
- JPRN-UMIN000045856
- Lead Sponsor
- Morinaga Milk Industry Co., Ltd., Food Ingredients & Technology Institute, R&D Division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Not provided
1) Subjects who have disease or serious medical history in liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism, etc. 2) Subjects who regularly use oral or nasal medications 3) Subjects with serious medication allergy, food allergy, or history of these 4) Subjects with severe perennial or seasonal allergic symptoms 5) Subjects who are scheduled to be vaccinated against COVID-19 from two weeks before the start of this study to the end of this study 6) Subjects who are pregnant, under lactation or expecting to be pregnant during this study 7) Subjects who participated in other study within 1 month prior to obtaining informed consent 8) Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method